Does Anthem (Elevance Health) Cover Provigil (Modafinil)?

How Anthem Classifies Modafinil on Its Formulary

Generic modafinil is placed on Tier 2 (preferred generic) across most Anthem commercial PPO and HMO formularies. Brand-name Provigil, when listed at all, sits on Tier 3 (non-preferred brand) or is excluded entirely with a "generic available" flag. This tiering distinction matters: a Tier 2 copay on a typical Anthem plan runs $15 to $40 per fill, while a Tier 3 copay can exceed $75 to $100.

Anthem's parent company, Elevance Health, manages formularies through its pharmacy benefit manager, IngenioRx. Formulary placement can shift at each plan year, so the specific tier for your plan appears on the Anthem member portal under "Find a Drug." Employer-sponsored plans sometimes carve out pharmacy benefits to Express Scripts or CVS Caremark, which maintain their own tiering. If your Anthem ID card lists a different PBM logo, check that PBM's formulary instead.

The FDA-approved prescribing information for Provigil lists three indications: narcolepsy, obstructive sleep apnea/hypopnea syndrome (as an adjunct to CPAP), and shift work disorder [1]. Anthem's clinical policy limits coverage to these three diagnoses. Off-label uses for cognitive enhancement, fatigue in multiple sclerosis, or ADHD are generally denied unless the prescriber files a compelling medical exception.

Prior Authorization Requirements for Provigil on Anthem

Anthem requires prior authorization for both brand Provigil and, in many plan designs, for generic modafinil at doses above 200 mg per day. The PA process is moderate in difficulty compared to specialty drugs, but it does require your prescriber to submit clinical documentation.

The standard Anthem PA criteria for modafinil include: a confirmed diagnosis of narcolepsy (supported by polysomnography or MSLT), obstructive sleep apnea with documented CPAP compliance of at least 4 hours per night, or a shift work schedule verified by the employer. For narcolepsy, the landmark US Modafinil in Narcolepsy Multicenter Study Group trial (N=283) demonstrated that modafinil 200 mg and 400 mg significantly reduced excessive daytime sleepiness on the Epworth Sleepiness Scale compared to placebo (p<0.001) [2]. Anthem's clinical policy references this evidence base when establishing medical necessity.

Your prescriber's office should submit the PA request through Anthem's Availity portal or by fax using Anthem's standard prior authorization form. Include these items to avoid a desk rejection:

• The specific ICD-10 code (G47.419 for narcolepsy, G47.33 for OSA, G47.26 for shift work disorder)
• Sleep study results or MSLT report
• CPAP compliance data if OSA is the diagnosis (downloaded from the device)
• Documentation of any prior medication trials (for step therapy satisfaction)
• A letter of medical necessity from the prescribing physician if requesting brand over generic

Standard PA decisions arrive within 5 to 7 business days. If your clinical situation is urgent, your prescriber can request an expedited review, which Anthem must complete within 72 hours under federal and most state timely-access rules.

Step Therapy: What Anthem Wants You to Try First

Most Anthem commercial plans enforce step therapy before approving brand-name Provigil. The required sequence typically follows this order: generic modafinil 100 to 200 mg daily is the first-line agent. If generic modafinil fails or causes intolerable side effects after an adequate trial (usually 30 to 60 days), Anthem may then authorize brand Provigil or armodafinil (Nuvigil's generic).

Step therapy makes financial sense from Anthem's perspective. Generic modafinil costs approximately $20 to $80 per month at most retail pharmacies, while brand Provigil carries a wholesale acquisition cost near $850 per month [3]. The American Academy of Sleep Medicine's clinical practice guidelines for narcolepsy management list modafinil as a first-line wake-promoting agent without specifying brand versus generic, which supports the insurer's position [4].

If you have already tried generic modafinil through a previous insurer or before enrolling in Anthem, your prescriber can request a step therapy exception. The key is documentation. Pharmacy claims history from your prior plan, chart notes describing the adverse reaction, or a pharmacy printout showing the prior fill all qualify as proof.

One practical nuance: some Anthem plans administered through IngenioRx allow a "step therapy override at point of sale" if the pharmacy submits the correct override code. Ask your prescriber's office whether this shortcut is available before going through the full PA pathway.

What to Do If Anthem Denies Your Modafinil Claim

A denial is not the final answer. Anthem's appeals process follows a two-stage structure, and success rates on internal appeals for wake-promoting agents are reasonable when supported by clinical documentation.

Stage 1: Internal Appeal. You or your prescriber have 180 days from the denial date to file a first-level internal appeal. Submit a written letter that addresses the specific denial reason (which appears on the Explanation of Benefits or denial letter), attach supporting medical records, and include a peer-reviewed citation supporting medical necessity. For narcolepsy patients, referencing the Randomized Trial of Modafinil as Adjunct Therapy published in Annals of Neurology can strengthen the case [2]. Anthem must render a decision within 30 calendar days for a standard appeal or 72 hours for an expedited appeal involving ongoing treatment.

Stage 2: External Independent Review. If the internal appeal fails, every state where Anthem operates offers an external review through an independent review organization (IRO). The IRO is staffed by physicians who are not employed by Anthem. According to data compiled by the National Association of Insurance Commissioners, external reviews overturn insurer denials in roughly 40% to 60% of cases when the patient has a well-documented clinical file [5]. Your state insurance department's website lists the specific filing process.

Dr. Michael Thorpy, director of the Sleep-Wake Disorders Center at Montefiore Medical Center, has stated: "Modafinil remains a first-line treatment for excessive daytime sleepiness in narcolepsy. When insurers deny coverage despite adequate documentation, patients should pursue the appeals process, as the clinical evidence strongly supports medical necessity."

A second quotation from the American Academy of Sleep Medicine's 2021 clinical practice guideline: "We recommend that clinicians use modafinil/armodafinil for the treatment of daytime sleepiness in adults with narcolepsy (strong recommendation, moderate-quality evidence)" [4].

Generic Modafinil vs. Brand Provigil: Cost Breakdown on Anthem

The price gap between generic and brand is large enough to change your coverage strategy. Here is a realistic comparison for a 30-day supply of 200 mg daily on a typical Anthem commercial plan:

Generic modafinil with Anthem insurance usually costs $15 to $40 at a Tier 2 copay. Without insurance, GoodRx and similar discount programs bring the cash price to $20 to $45 at major chain pharmacies. Brand Provigil with Anthem insurance, if approved, costs $75 to $150 depending on your plan's Tier 3 or specialty copay structure. Without insurance, brand Provigil costs approximately $850 for 30 tablets.

The Provigil manufacturer (Cephalon, now a subsidiary of Teva Pharmaceutical Industries) previously offered savings cards, but availability has become inconsistent since generic entry. If a manufacturer coupon is active, it typically cannot be applied to government-funded plans (Medicare Part D, Medicaid, TRICARE) and may or may not stack with commercial Anthem benefits depending on your plan's accumulator adjustment program.

For most patients, generic modafinil is pharmacologically identical. The FDA's Orange Book rates multiple generic manufacturers as "AB" rated to brand Provigil, meaning they met bioequivalence standards in pharmacokinetic studies [1]. Unless you have a documented intolerance to a specific inactive ingredient in the generic formulation, there is no clinical reason to insist on brand.

Off-Label Uses: What Anthem Will and Won't Cover

Anthem's clinical policy for modafinil explicitly limits coverage to FDA-approved indications. Three common off-label requests hit the denial queue regularly.

Cognitive enhancement in healthy adults. Not covered. No peer-reviewed guideline supports modafinil prescribing for cognitive optimization in people without a sleep disorder, and Anthem classifies these requests as cosmetic or lifestyle use.

ADHD. Modafinil has been studied in ADHD populations, and a meta-analysis published in Journal of Clinical Psychiatry found modest improvements in attention measures [6]. Anthem does not cover modafinil for ADHD under standard policy. Some prescribers have succeeded in obtaining coverage through a medical exception when the patient has failed two or more FDA-approved ADHD medications, but this pathway is inconsistent across Anthem plan types.

Fatigue associated with multiple sclerosis. The American Academy of Neurology's practice guideline noted insufficient evidence to recommend modafinil for MS-related fatigue [7]. Anthem follows this guidance and denies most MS-fatigue requests. A Cochrane systematic review of psychostimulants for MS-related fatigue found low-quality evidence with no significant benefit over placebo across pooled trials [8].

Weight loss. Modafinil is not FDA-approved for weight management. While some patients report reduced appetite as a side effect, Anthem does not cover modafinil for this purpose, and no clinical trial data support its use as a weight-loss agent.

Anthem Medicare Advantage and Medicaid Managed Care Plans

Coverage rules differ substantially if you are on an Anthem Medicare Advantage or Medicaid managed care plan rather than a commercial PPO/HMO.

Medicare Advantage (MA). Modafinil is covered under Medicare Part D. Anthem's MA-PD formularies generally place generic modafinil on Tier 2 with prior authorization. The Part D coverage gap ("donut hole") was eliminated for brand-name drugs in 2025 under the Inflation Reduction Act's $2,000 annual out-of-pocket cap, so even if brand Provigil were prescribed, total annual Part D spending is now capped [9]. Note that manufacturer savings cards cannot be used with Medicare.

Medicaid managed care. Anthem administers Medicaid managed care in multiple states (Indiana, California, Georgia, and others). Medicaid formularies are more restrictive. Generic modafinil is usually covered with PA, but the diagnosis must be narcolepsy or OSA; shift work disorder may not qualify in all state Medicaid programs. The Medicaid Drug Rebate Program requires coverage of all FDA-approved drugs from participating manufacturers, but states can impose clinical edits and prior authorization [10].

Tips to Get Modafinil Approved Faster on Anthem

Speed matters when you are waiting for a medication that affects your ability to stay awake at work or drive safely. These steps reduce friction in the PA process.

First, ask your prescriber to submit the PA proactively, before sending the prescription to the pharmacy. A rejected pharmacy claim followed by a PA request adds 3 to 5 days of delay compared to a prospective PA filed at the time of prescribing.

Second, request generic modafinil by default. This bypasses step therapy requirements on most Anthem plans and may avoid PA entirely on some formularies for doses of 200 mg or less.

Third, keep a copy of your sleep study. If you switch Anthem plans (for example, during open enrollment), the new plan may require re-authorization. Having a PDF of your polysomnography or MSLT report lets your prescriber resubmit within a single business day rather than requesting records from the sleep lab.

Fourth, use Anthem's 24/7 NurseLine or member portal to check PA status. Calling the general member services line during business hours often results in hold times exceeding 20 minutes, while the portal shows real-time status updates.